UNITED THERAPEUTICS Corp (UTHR) SEC Filings & Filing Highlights

Review SEC filings, SEC-derived company events, filing highlights, source excerpts, and material disclosure activity for UNITED THERAPEUTICS Corp (UTHR).

Company Snapshot

Company: UNITED THERAPEUTICS Corp (UTHR)
Ticker: UTHR
Market Cap: $22.5B
Latest Price: $530.84
Industry: Biotech & Pharma

Open insider transactions

UNITED THERAPEUTICS Corp (UTHR) Recent SEC Filing Highlights

Recent SEC filings, filing events, and disclosure highlights indexed for UNITED THERAPEUTICS Corp (UTHR).

Event	Form	Date
On June 26, 2026, the Company held its 2026 Annual Meeting of Shareholders. The Company’s share...On June 26, 2026, the Company held its 2026 Annual Meeting of Shareholders. The Company’s shareholders considered four matters, each of whi...	8-K5.07	2026-06-29
As described in Item 5.07 below, on June 26, 2026, at the 2026 Annual Meeting of Shareholders o...As described in Item 5.07 below, on June 26, 2026, at the 2026 Annual Meeting of Shareholders of United Therapeutics Corporation (the Compa...	8-K5.02	2026-06-29
United Therapeutics Corporation Reports First Quarter 2026 Financial ResultsUnited Therapeutics Corporation Reports First Quarter 2026 Financial Results	8-K2.02	2026-05-06
United Therapeutics plans to seek priority review of a supplemental New Drug Application to be...United Therapeutics Corporation Announces TETON-1 Pivotal Study of Tyvaso® Meets Primary Endpoint for Treatment of Idiopathic Pulmonary Fib...	8-K8.01	2026-03-30
United Therapeutics Corporation Announces $2 Billion Stock Repurchase Authorization and Enters...United Therapeutics Corporation Announces $2 Billion Stock Repurchase Authorization and Enters into $1.5 Billion Accelerated Share Repurcha...	8-K7.01	2026-03-09

Live data loads in the app

This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.